Loading…
Sunshine Biopharma, Inc. is projected to rise to $0.6357 by 2027, a +50% move from its current price of $0.4244. SBFM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.3856 | $0.4253 | $0.469 | +0.20% |
| May 30 | $0.3711 | $0.4261 | $0.4894 | +0.41% |
| May 31 | $0.3604 | $0.427 | $0.5059 | +0.62% |
| Jun 1 | $0.3518 | $0.4279 | $0.5204 | +0.82% |
| Jun 2 | $0.3445 | $0.4288 | $0.5336 | +1.03% |
| Jun 3 | $0.3381 | $0.4296 | $0.546 | +1.24% |
| Jun 4 | $0.3323 | $0.4305 | $0.5578 | +1.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3323 | $0.4305 | $0.5578 | +1.44% |
| Week 2 | $0.3028 | $0.4367 | $0.6299 | +2.91% |
| Week 3 | $0.2829 | $0.443 | $0.6938 | +4.39% |
| Week 4 | $0.2678 | $0.4494 | $0.7543 | +5.90% |
| Week 5 | $0.2555 | $0.4559 | $0.8134 | +7.43% |
| Week 6 | $0.2453 | $0.4625 | $0.8721 | +8.98% |
| Week 7 | $0.2365 | $0.4692 | $0.9308 | +10.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is based in Fort Lauderdale, Florida.
The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications.
Sunshine Biopharma, Inc. is a healthcare stock in the pharmaceutical sector.
Current price: $0.4244. Market capitalization: $6.86M. Market rank: 5197.
The price outlook shows a bullish trajectory beginning in 2027, with year-by-year forecasts indicating rising averages and notable ROIs through 2050. The 2026 average is $0.4244, and the forecast grows in subsequent years, culminating in higher averages and ROIs by 2040 and 2050.
A major floor 33.1% below — a decisive break under it would weaken the trend.
The nearest floor, 33.1% below — buyers have tended to step in here.
The nearest ceiling, 159.2% above — a clean break opens room to run.
A major ceiling 234.3% above — clearing it would confirm fresh momentum.
Key SBFM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SBFM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.441 | Sell | $0.4502 | Sell |
| MA 10 | $0.4568 | Sell | $0.5258 | Sell |
| MA 20 | $0.7496 | Sell | $0.6654 | Sell |
| MA 50 | $0.917 | Sell | $0.8655 | Sell |
| MA 100 | $1.06 | Sell | $1.04 | Sell |
| MA 200 | $1.30 | Sell | $4.31 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.26 | Neutral |
| Stoch RSI (14) | 46.55 | Neutral |
| CCI (20) | -74.13 | Neutral |
| Williams %R (14) | -82.41 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -59.62 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 17.59 | Buy |
| TRIX (15) | -1.97 | Sell |
| Awesome (5,34) | -0.41 | Sell |
| Ultimate (7,14,28) | 47.66 | Neutral |
| Momentum (10) | -0.63 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 0.45 | Sell |
| ADX (14) | 27.11 | Sell |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is Bearish in sentiment. RSI14 is 30. The SMA50 is $0.917 and the SMA200 is $1.30. Support is at $0.284 and resistance at $1.10. The 30-day range spans from $0.2227 to $0.809. Annualized volatility is 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.284 | $0.4244 | $0.6895 | 0% | Neutral | |
| $0.4575 | $0.6357 | $0.9559 | +50% | Bullish | |
| $0.5166 | $0.7618 | $1.22 | +80% | Bullish | |
| $0.438 | $0.6799 | $1.14 | +60% | Bullish | |
| $0.3604 | $0.5862 | $1.02 | +38% | Bullish | |
| $0.3768 | $0.6404 | $1.16 | +51% | Bullish | |
| $0.3116 | $0.5523 | $1.03 | +30% | Bullish | |
| $0.358 | $0.6606 | $1.26 | +56% | Bullish | |
| $0.4663 | $0.8951 | $1.75 | +111% | Bullish | |
| $0.4265 | $0.8509 | $1.70 | +101% | Bullish | |
| $0.4619 | $1.03 | $2.26 | +142% | Bullish | |
| $0.7581 | $1.68 | $3.87 | +297% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.284 | $0.4244 | $0.5059 | +0.00% |
| June 2026 | $0.3935 | $0.472 | $0.5865 | +11.21% |
| July 2026 | $0.4194 | $0.5115 | $0.6519 | +8.38% |
| August 2026 | $0.3965 | $0.4901 | $0.6368 | -4.18% |
| September 2026 | $0.3902 | $0.4877 | $0.6436 | -0.49% |
| October 2026 | $0.4175 | $0.5272 | $0.7054 | +8.09% |
| November 2026 | $0.4139 | $0.5274 | $0.7143 | +0.04% |
| December 2026 | $0.3916 | $0.5033 | $0.6895 | -4.56% |
Click any year to see its month-by-month SBFM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sunshine Biopharma, Inc.'s 2026 outlook centres on $0.4244, within a $0.284 to $0.6895 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, SBFM could reach as high as $0.9559, with a base case around $0.6357 and support toward $0.4575 — roughly +50% from $0.4244. Momentum favours further upside here.
Expect SBFM to range from $0.5166 to $1.22 through 2028. The $0.7618 average target implies a +80% move from current prices. That is up +20% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The SBFM price prediction for 2029 points to an average of $0.6799 (low $0.438, high $1.14) — a potential gain of +60% on today's $0.4244. Momentum favours further upside here.
In 2030, SBFM is projected to trade between $0.3604 and $1.02, averaging $0.5862 — a potential gain of +38% from today's $0.4244. That is -14% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Sunshine Biopharma, Inc.'s 2031 outlook centres on $0.6404, within a $0.3768 to $1.16 range. That is up +9% on the projected 2030 average. That marks a +51% change versus current levels. Momentum favours further upside here.
By 2032, SBFM could reach as high as $1.03, with a base case around $0.5523 and support toward $0.3116 — roughly +30% from $0.4244. Buyers look set to stay in control over this stretch.
Expect SBFM to range from $0.358 to $1.26 through 2033. The $0.6606 average target implies a +56% move from current prices. That is up +20% on the projected 2032 average. Momentum favours further upside here.
The SBFM price prediction for 2034 points to an average of $0.8951 (low $0.4663, high $1.75) — a potential gain of +111% on today's $0.4244. Buyers look set to stay in control over this stretch.
In 2035, SBFM is projected to trade between $0.4265 and $1.70, averaging $0.8509 — a potential gain of +101% from today's $0.4244. That is -5% versus the projected 2034 average. Momentum favours further upside here.
Sunshine Biopharma, Inc.'s 2040 outlook centres on $1.03, within a $0.4619 to $2.26 range. That is up +21% on the projected 2035 average. That marks a +142% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, SBFM could reach as high as $3.87, with a base case around $1.68 and support toward $0.7581 — roughly +297% from $0.4244. Momentum favours further upside here.
Investing $1,000 in SBFM today (≈ 2,356.267672 SBFM) could be worth
$3,969.32
+$2,969.32 (+297%) by 2050 · US Dollar
Based on the average projected SBFM price of $1.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SBFMwould be worth at today's price.
$1,000 invested in SBFM on May 27, 2025 (≈ 699.300725 SBFM) would be worth
$296.78
-$703.22 (-70.3%) today · 0.30× · US Dollar
Based on a SBFM entry price of $1.43 vs. today's $0.4244.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.367 | $1,156.4 | +15.6% |
| 1 month ago | $0.982 | $432.18 | -56.8% |
| 3 months ago | $1.23 | $345.04 | -65.5% |
| 6 months ago | $1.45 | $292.89 | -70.7% |
| 1 year ago | $1.43 | $296.78 | -70.3% |
| All time (4.3y) ago | $4,780 | $0.09 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SBFM forecast.
Our base-case forecast reaches $0.85 around 2034.
Implied market cap at $0.85: $13.74M
The multi-year forecast shows continued upside with bullish sentiment from 2027 onward. In 2030, the average price is $0.5862 with an ROI of 38.1% and a bullish sentiment. By 2040, the forecast increases to an average of $1.03 with an ROI of 141.8% and a bullish sentiment.
In 2050, the average is projected at $1.68 with an ROI of 296.9% and a bullish sentiment.
These figures imply rising average prices over time and meaningful upside potential, but they are not guarantees. The plan reflects a long horizon where volatility remains a consideration, and near-term dynamics show a bearish backdrop in the current technical picture.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $0.5862 with a max of $1.02 and a min of $0.3604, and an ROI of 38.1%. The sentiment for 2030 is BULLISH.
Forecasts indicate bullish sentiment from 2027 through 2050 with rising averages and ROIs (e.g., 49.8% in 2027, 141.8% by 2040, and 296.9% by 2050), but the 2026 outlook is Neutral and current conditions show Bearish momentum. These are estimates, not guarantees.
Yes. The max forecasts exceed $1 in several years: $1.02 in 2030, $1.22 in 2028, $1.16 in 2031, $1.75 in 2034, $2.26 in 2040, and $3.87 in 2050.
Current price is $0.4244. Market capitalization is $6.86M, with a market rank of 5197.
The short-term picture is Bearish with RSI of 30. The 30-day range is $0.2227 to $0.809, while the price sits near a support of $0.284 and a resistance of $1.10, and volatility is high at 200%.
Sunshine Biopharma, Inc. Community Discussion
0Share your Sunshine Biopharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.